Desjardins Global Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $24.9K | Buy |
77
+2
| +3% | +$646 | ﹤0.01% | 587 |
|
|
2023
Q3 | $26.9K | Sell |
75
-75
| -50% | -$26.9K | ﹤0.01% | 584 |
|
|
2023
Q2 | $56.8K | Buy |
150
+76
| +103% | +$28.8K | 0.01% | 525 |
|
|
2023
Q1 | $35K | Buy |
+74
| New | +$35K | ﹤0.01% | 537 |
|
|
2022
Q4 | – | Sell |
-1,438
| Closed | -$600K | – | 484 |
|
|
2022
Q3 | $600K | Hold |
1,438
| – | – | 0.08% | 207 |
|
|
2022
Q2 | $712K | Sell |
1,438
-807
| -36% | -$400K | 0.09% | 189 |
|
|
2022
Q1 | $1.26M | Sell |
2,245
-279
| -11% | -$157K | 0.11% | 172 |
|
|
2021
Q4 | $1.91M | Buy |
+2,524
| New | +$1.91M | 0.16% | 151 |
|